GCG and neurodegenerative disease: Previous works on this matter pointed out that GLP-1 can cross the blood-brain barrier, and therefore the central effect of GLP-1 may have the potential to protect against neurodegenerative diseases and reduce Aβ protein precursor and Aβ deposition in the brain [7,8].